Search alternatives:
ppm decrease » _ decrease (Expand Search), nn decrease (Expand Search), pa decreased (Expand Search)
non decrease » nn decrease (Expand Search), point decrease (Expand Search), note decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
ppm decrease » _ decrease (Expand Search), nn decrease (Expand Search), pa decreased (Expand Search)
non decrease » nn decrease (Expand Search), point decrease (Expand Search), note decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
341
-
342
SUI-sEVs decreased the proliferation of fibroblasts.
Published 2021“…<p>Fibroblasts were cultured with control medium or medium containing SUI-sEVs or medium containing non SUI-sEVs for 24, 48 and 72h, respectively. (A) Cell proliferation was determined with a CCK-8 assay. …”
-
343
Regenerating axons are increased by ATRA and decreased by clodronate.
Published 2021“…<p>(A—E) Confocal images of immunohistochemical staining of growing axons with anti-GAP43 antibody (green), in longitudinal sections of the optic nerve at 2 weeks after axotomy. …”
-
344
Depletion of ERp29 decreases cellular Proinsulin.
Published 2020“…<p>Min-6 cells were transfected with ERp29-targeting siRNA or with a non-targeting control siRNA. (A) The resulting depletion of ERp29 and its effect on Proinsulin abundance were then assayed by immunoblot. …”
-
345
-
346
-
347
-
348
-
349
-
350
Preoperative and postoperative questionnaire scores of groups A, B, C, D, E, F, and G.
Published 2021Subjects: -
351
Decrease of p38 MAPK phosphorylation in HL60 and KG1a cells exposed to 5-Fluorouridine (FUrd) after cell pretreatment with p38 MAPK pathway inhibitor SB202190.
Published 2022“…<p>The KG1a and HL60 cells were pre-treated with 10 μM SB202190 for 2 h incubation then followed by the cell treatment with 10 μM of FUrd. …”
-
352
Table_1_v2_A long waiting time from diagnosis to treatment decreases the survival of non-small cell lung cancer patients with stage IA1: A retrospective study.docx
Published 2022“…After adjusting for other confounders, the waiting time was identified as an independent prognostic factor.</p>Conclusions<p>A long waiting time before treatment may decrease the survival of stage IA1 NSCLC patients. …”
-
353
-
354
-
355
-
356
Table_1_Cysteinyl Leukotriene Receptor Antagonists Associated With a Decreased Incidence of Cancer: A Retrospective Cohort Study.docx
Published 2022“…</p>Result<p>We followed-up (median: 5.6 years) 188,906 matched patients (94,453 LTRA users and 94,453 non-users). LTRA use was associated with a decreased risk of cancer (adjusted HR [aHR] = 0.85, 95% confidence interval [CI] = 0.83–0.87). …”
-
357
-
358
-
359
-
360